HeartBeam, Inc. will attend the JP Morgan 2026 Annual Healthcare Conference, taking place January 12-15, 2026, at the Westin St. Francis Hotel in San Francisco, CA. The company plans to discuss its upcoming limited U.S. commercial launch and recent FDA clearance for its 12-lead ECG synthesis software.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartbeam Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260105542890) on January 05, 2026, and is solely responsible for the information contained therein.
Comments